PharVision Advisers’s Lloyds Banking Group LYG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,629
Closed -$73.6K 100
2026
Q1
$73.6K Buy
+14,629
New +$80.3K 0.75% 69
2025
Q4
Sell
-10,340
Closed -$46.9K 872
2025
Q3
$46.9K Buy
+10,340
New +$45.2K 0.03% 650

Other funds holding LYG

PharVision Advisers's LYG Position: Q2 2026 in Review

PharVision Advisers sold out of Lloyds Banking Group (LYG) in Q2 2026, closing a stake of 14,629 shares — an estimated $73.6K sold.

PharVision Advisers first reported a position in LYG in Q3 2025 and held it in 2 quarters. The position peaked at $73.6K in Q1 2026. 614 funds tracked by Wall St. Rank hold LYG as of Q2 2026.

  • PharVision Advisers reported no remaining Lloyds Banking Group position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 14,629 Lloyds Banking Group shares in Q2 2026, an estimated $73.6K.
  • PharVision Advisers first reported a position in Lloyds Banking Group in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Lloyds Banking Group position peaked at $73.6K in Q1 2026.
  • 614 funds tracked by Wall St. Rank held Lloyds Banking Group as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.